Ottobock SE & Co. KGaA (ETR:OBCK)

Market Cap	3.06B -31.1%
Revenue (ttm)	1.73B +5.5%
Net Income	128.60M +122.1%
EPS	2.03 +118.7%
Shares Out	63.99M
PE Ratio	23.58
Forward PE	14.34
Dividend	0.97 (2.03%)
Ex-Dividend Date	May 20, 2026

Volume	49,226
Open	47.40
Previous Close	47.55
Day's Range	47.20 - 48.35
52-Week Range	45.56 - 76.35
Beta	n/a
Analysts	Strong Buy
Price Target	78.63 (+64.67%)
Earnings Date	Nov 12, 2026

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and lower extremities; mechanical prostheses and technologically sophistic...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 9,406
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: OBCK

Financial Performance

In 2025, Ottobock SE & Co. KGaA's revenue was 1.68 billion, an increase of 4.69% compared to the previous year's 1.60 billion. Earnings were 90.20 million, an increase of 198.68%.

Analyst Summary

According to 8 analysts, the average rating for OBCK stock is "Strong Buy." The 12-month stock price target is €78.63, which is an increase of 64.67% from the latest price.

Price Target

€78.63

(64.67% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Nov 4, 2026

Data Sources Report a data error